-
Mashup Score: 0This Week's Infectious Disease News Update - 6 month(s) ago
In this week’s infectious disease news, the Novavax COVID-19 booster gets authorized in the US; Moderna reports topline data on its influenza-COVID-19 combination vaccine; the differences between live biotherapeutic products and conventional FMTs; and the influence of alcohol on hepatitis C treatment.
Source: www.contagionlive.comCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0
mRNA-1083 (Moderna) was found comparable to the standard dose of Fluarix (GSK) in adults aged 50 to 64 years and Fluzone HD ( Sanofi) for influenza and Spikevax (Moderna) for COVID-19.
Source: www.pharmacytimes.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Exciting news on the mRNA-1083 vaccine! Phase 1/2 trial results show it matches licensed flu vaccines and offers strong COVID-19 protection. A promising step toward combo vaccines. #COVID19 #FluVaccine #Moderna #Vaccines Read More: https://t.co/Dj4n06WujX
-
-
Mashup Score: 0
Although both are safe and effective, the Moderna COVID-19 vaccine was linked to greater protection and a slightly lower risk for adverse events compared with the Pfizer-BioNTech vaccine in older adults, data in JAMA Network Open show. Daniel A. Harris, PhD, a research scientist at Brown University School of Public Health, and colleagues wrote that head-to-head comparisons of the messenger
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
💉 The #Moderna #COVID19 vaccines had lower risk of adverse events versus #Pfizer's #vaccine and was linked to greater protection against #infection. #healthnews #MedTwitter https://t.co/WdhBcD8I21
-
-
Mashup Score: 0Moderna Files for FDA Authorization for This Year’s COVID-19 Vaccine - 10 month(s) ago
The vaccine manufacturer has incorporated spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 for its mRNA-1273.815 COVID-19 vaccine.
Source: ContagionLiveCategories: Infectious Disease, Latest HeadlinesTweet-
#Moderna has incorporated spike proteins for the XBB.1.5 sublineage of SARS-CoV-2 for its mRNA-1273.815 #COVID19 vaccine. #IDtwitter #Medtwitter https://t.co/QnWCVrHNHQ
-
-
Mashup Score: 0COVID-19 Bivalent Boosters Associated With Few Definitive Hematologic AEs | ASH Clinical News | American Society of Hematology - 10 month(s) ago
Skip Nav Destination May 9, 2023 Brandon May is a medical journalist based in Detroit. A cross-sectional study of U.S. safety data found few hematologic adverse events (AEs) after administration of the authorized COVID-19 bivalent…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
A study of U.S. safety data found few #hematologic adverse events (AEs) following administration of the #COVID19 bivalent booster vaccines from #Pfizer and #Moderna, as most AEs could not be definitively attributed to vaccination https://t.co/tmFmiftiRe
-
-
Mashup Score: 0FDA and CDC Update COVID-19 Vaccine Recommendations - 1 year(s) ago
The CDC updated and simplified its vaccine recommendations on April 19, 2023, and the Moderna and Pfizer-BioNTech mRNA bivalent COVID-19 vaccines should be used for all vaccinations in the US.
Source: Infection Control TodayCategories: Infectious Disease, Latest HeadlinesTweet-
The CDC updated and simplified its vaccine recommendations , and all US citizens should use the Moderna and Pfizer-BioNTech mRNA bivalent COVID-19 vaccines for all vaccinations. https://t.co/x0ukWgaSVd #FDA #CDC #COVID19 #Bivalent #Moderna #Pfizer
-
-
Mashup Score: 23
The reversal came as Sen. Bernie Sanders scheduled a hearing next month about Moderna’s initial decision to charge Americans for its shot.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
Interesting development today in the "what will Covid vaccines cost after the public health emergency ends?" saga. Does this put the ball in #Pfizer's court? #Moderna https://t.co/EVvTjA1E5g
-
In about-face, Moderna vows Americans won’t have to pay for its Covid-19 vaccine.. https://t.co/UH7qpXfj2P #Covid19 #vaccines #BernieSanders $MRNA $PFE
-
-
Mashup Score: 0
With these results, the company plans to submit their investigational vaccine, MRNA-1345, for regulatory approval in the first half of 2023.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#ICYMI #Moderna reported its #RSV vaccine for seniors demonstrated an efficacy of 83.7% against RSV-associated lower respiratory tract disease in its phase 3 trial. They plan to file for regulatory approval in the first half of 2023. https://t.co/7yVh7ID5ik
-
-
Mashup Score: 5Dr. Tedros, WHO Director-General, presents Oxfam resolution at Moderna's annual shareholder meeting - 1 year(s) ago
Dr. Tedros, WHO Director-General, presents Oxfam resolution at Moderna’s annual shareholder meeting to urge them to share vaccine technology with the world.G…
Source: YouTubeCategories: HIV/AIDS, Latest HeadlinesTweet-
RT @RajThamotheram: @DrTedros was spot on with his call to #Moderna, #Pfizer & other #BigPharma *investors*. https://t.co/9WKB7hvCw6 It wi…
-
-
Mashup Score: 4Dr. Tedros, WHO Director-General, presents Oxfam resolution at Moderna's annual shareholder meeting - 1 year(s) ago
Dr. Tedros, WHO Director-General, presents Oxfam resolution at Moderna’s annual shareholder meeting to urge them to share vaccine technology with the world.G…
Source: YouTubeCategories: Infectious Disease, Latest HeadlinesTweet-
RT @RajThamotheram: @DrTedros was spot on with his call to #Moderna, #Pfizer & other #BigPharma *investors*. https://t.co/9WKB7hvCw6 It wi…
-
This week: #Novavax #COVID19 booster gets FDA authorization; #Moderna reports data on its influenza-COVID-19 combination vaccine; the differences between live biotherapeutic products and conventional FMTs; and the influence of alcohol on HCV Treatment. https://t.co/yDzM6RARtL https://t.co/YE4OUa6FwT